Radiologists May Be Able to Predict Presence of DCIS, Invasive Cancer with Fairly High Accuracy, Study Suggests.

Thursday, April 20, 2017

Diagnostic Imaging (4/18) reports research suggests “radiologists may be able to predict the presence of ductal carcinoma in situ (DCIS) and invasive cancer with fairly high accuracy.” The findings were published in the American Journal of Roentgenology. 

Some Patients with Breast Cancer Undergoing Preop Mammography, Ultrasound Would Be More Accurately Imaged for Tumor Size with Breast MRI, Research Suggests

Tuesday, April 18, 2017

HealthImaging (4/17, Pearson) reports that research suggests “a third of breast-cancer patients undergoing preoperative mammography and ultrasound would be more accurately imaged for tumor size with breast MRI.” The findings were published online in the Journal of Surgical Oncology. 

Screening Breast MRI May Be Valuable Tool in Routine Clinical Practice for a Variety of Women at Elevated Risk for Breast Cancer, Study Suggests

Tuesday, April 18, 2017

Aunt Minnie (4/18, Yee) reports that research suggests “screening breast MRI is a valuable tool in routine clinical practice across a spectrum of women at elevated risk for breast cancer – not just those who meet the conventional definitions of high risk.” The findings were published in Academic Radiology. Aunt Minnie adds that “overall, the study suggests that breast MRI can be used to screen a wider spectrum of women than just those covered by BI-RADS 5, the team wrote – which only expands the screening arsenal.” The authors wrote, “Our results met the ACR BI-RADS audit benchmarks for cancer detection rate, PPV2, and PPV3, supporting the adoption of these benchmarks in routine clinical practice.” 

Breast MRI-Guided VAB Has Low False Omission Rate, Research Indicates

Tuesday, April 18, 2017

Diagnostic Imaging (4/17) reports that research suggests “breast MRI-guided vacuum-assisted biopsy (VAB) has a low false omission rate, and MRI follow-up of lesions with concordant benign MRI-guided VAB histopathology results may not be warranted.” The findings were published in the American Journal of Roentgenology 

SBI Member Dr. Michael Linver Writes About Controversies in Breast Screening

Tuesday, April 18, 2017

The ongoing attacks directed against screening mammography remain a source of bitter disappointment for those of us who are focused on another war on a daily basis — that against a real killer known as breast cancer. We have a powerful weapon in the high-quality mammogram used as a screening method: We know this based on real science, stemming from the randomized controlled trials (RCTs) conducted over the past 30 years that tested the impact of early detection on the breast cancer death rate.